BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

689 related articles for article (PubMed ID: 18412174)

  • 1. Computational chemistry approaches to drug discovery in signal transduction.
    Fischer PM
    Biotechnol J; 2008 Apr; 3(4):452-70. PubMed ID: 18412174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Editorial: Novel approaches to drug discovery in signal transduction.
    Dekker L
    Biotechnol J; 2008 Apr; 3(4):428-9. PubMed ID: 18412180
    [No Abstract]   [Full Text] [Related]  

  • 3. The application of cell-based label-free technology in drug discovery.
    Xi B; Yu N; Wang X; Xu X; Abassi YA
    Biotechnol J; 2008 Apr; 3(4):484-95. PubMed ID: 18412175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-based assays in GPCR drug discovery.
    Siehler S
    Biotechnol J; 2008 Apr; 3(4):471-83. PubMed ID: 18383022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G-protein-coupled receptor-focused drug discovery using a target class platform approach.
    Heilker R; Wolff M; Tautermann CS; Bieler M
    Drug Discov Today; 2009 Mar; 14(5-6):231-40. PubMed ID: 19121411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Docking and scoring in virtual screening for drug discovery: methods and applications.
    Kitchen DB; Decornez H; Furr JR; Bajorath J
    Nat Rev Drug Discov; 2004 Nov; 3(11):935-49. PubMed ID: 15520816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudoreceptor models in drug design: bridging ligand- and receptor-based virtual screening.
    Tanrikulu Y; Schneider G
    Nat Rev Drug Discov; 2008 Aug; 7(8):667-77. PubMed ID: 18636071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-based assays in GPCR drug discovery. In this issue.
    Biotechnol J; 2008 Apr; 3(4):430. PubMed ID: 18412181
    [No Abstract]   [Full Text] [Related]  

  • 9. A molecular thermodynamic view of DNA-drug interactions: a case study of 25 minor-groove binders.
    Shaikh SA; Ahmed SR; Jayaram B
    Arch Biochem Biophys; 2004 Sep; 429(1):81-99. PubMed ID: 15288812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De novo drug design: integration of structure-based and ligand-based methods.
    Dean PM; Lloyd DG; Todorov NP
    Curr Opin Drug Discov Devel; 2004 May; 7(3):347-53. PubMed ID: 15216939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for designing GPCR-focused libraries and screening sets.
    Jimonet P; Jäger R
    Curr Opin Drug Discov Devel; 2004 May; 7(3):325-33. PubMed ID: 15216936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The many roles of computation in drug discovery.
    Jorgensen WL
    Science; 2004 Mar; 303(5665):1813-8. PubMed ID: 15031495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular modeling of hydration in drug design.
    Mancera RL
    Curr Opin Drug Discov Devel; 2007 May; 10(3):275-80. PubMed ID: 17554853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput virtual screening for drug discovery in parallel.
    Toledo-Sherman LM; Chen D
    Curr Opin Drug Discov Devel; 2002 May; 5(3):414-21. PubMed ID: 12058617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Informatics and modeling challenges in fragment-based drug discovery.
    Hubbard RE; Chen I; Davis B
    Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of pharmacology data and the prediction of adverse drug reactions and off-target effects from chemical structure.
    Bender A; Scheiber J; Glick M; Davies JW; Azzaoui K; Hamon J; Urban L; Whitebread S; Jenkins JL
    ChemMedChem; 2007 Jun; 2(6):861-73. PubMed ID: 17477341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-directed combinatorial library design.
    Zhou JZ
    Curr Opin Chem Biol; 2008 Jun; 12(3):379-85. PubMed ID: 18328830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and virtual screening of target libraries.
    Rognan D
    J Physiol Paris; 2006; 99(2-3):232-44. PubMed ID: 16459061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel 2D fingerprints for ligand-based virtual screening.
    Ewing T; Baber JC; Feher M
    J Chem Inf Model; 2006; 46(6):2423-31. PubMed ID: 17125184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approaches to the description and prediction of the binding affinity of small-molecule ligands to macromolecular receptors.
    Gohlke H; Klebe G
    Angew Chem Int Ed Engl; 2002 Aug; 41(15):2644-76. PubMed ID: 12203463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.